Nearly every American household — mine included, sadly — has been touched in one way or another, by the scourge of Alzheimer’s disease. This is true across demographics, income brackets, and political identities.

Today, more than seven million people in the United States live with this illness, and millions more are caring for loved ones who can no longer take care of themselves. Cognitive decline —once thought of as an unavoidable part of aging — is no longer a foregone conclusion, however. Modern science is giving us the chance to intervene earlier and may soon allow us to prevent the disease entirely.

Unfortunately, public policy has not kept up with the science. Now, President Donald Trump and Congress have an unprecedented opportunity to change that by passing the newly released Alzheimer’s Screening and Prevention (ASAP) Act.

This bipartisan, bicameral legislation — introduced in November by Republican Rep. Vern Buchanan of Florida and Democratic Rep. Paul Tonko of New York with Republican Sen. Susan Collins of Maine and Democratic Sen. Catherine Cortez Masto of Nevada introducing........

© Independent Journal Review